Maryland Medical Cannabis Coalition Call for Nominations
Friday, May 24, 2019
The Natalie M. LaPrade Medical Cannabis Commission is an independent commission that functions within the Maryland Department of Health.
The purpose of the Commission is to develop policies, procedures, guidelines, and regulations to implement programs to make medical cannabis available to qualifying patients in a safe and effective manner.
Total Number: 13
1) The Secretary of Health, or the Secretary’s designee.
2) Nine members appointed by the Governor with the advice and consent of the Senate:
- Two licensed noncertified providers who are physicians, dentists, podiatrist, nurse practitioners or nurse midwives.
- One nurse or other health care provider experience in hospice, nominated by a State hospice trade association.
- One pharmacist licensed in the State, nominated by a State research institution or trade association; and
- One scientist who has experience in the science of cannabis, nominated by a State research institution
- Four members with substantial experience: As an executive with fiduciary responsibilities for a large organization or foundation; In an academic field relating to health, agriculture, finance, or addiction treatment; or As a professional in a profession relating to health, agriculture, finance, or addiction treatment.
3) Three members are appointed by the Governor:
- One member from a list of three individuals recommended by the President of the Senate;
- One member from a list of three individuals recommended by the Speaker of the House of Delegates; and
- One member from either of the lists from the President or the Speaker.
MSHP is seeking one nominee for the Pharmacist seat as described above (see bold bullet). Interested pharmacists should submit the nomination form no later than Monday, June 10 to be considered by the MSHP Board of Directors. Upon selection, the nominee will be responsible for completing additional documentation as required by the state of Maryland.